Pharma stocks a growing healthcare sub-segment
Singapore
EVEN though pharmaceuticals is one of the smaller sub-segments in the Singapore Exchange's (SGX's) cluster of healthcare stocks, its year-to-date market cap-weighted average total return of 7.3 per cent is almost double that of the 3.8 per cent generated by the SGX All Healthcare Index - the benchmark for listed healthcare companies here.
The six stocks are: Tianjin ZhongXin Pharmaceutical Group, Haw Par Corporation, iX Biopharma, Suntar Eco-City, Pharmesis International and Star Pharmaceutical.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Wall Street Journal moves Asia headquarters from Hong Kong to Singapore
Macquarie sees biggest profit dip in 15 years on commodities downturn
HSBC appoints ex-Citi banker as new Singapore head of global banking
H2G Green chief to stand trial on Aug 5 amid MOM probe
Dasin Retail Trust’s trustee-manager chairman, directors deny allegations of misconduct
Microsoft adds security chiefs to product groups in wake of hacking woes